COPPOLA, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 7.641
EU - Europa 7.485
AS - Asia 1.128
SA - Sud America 19
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 16.298
Nazione #
US - Stati Uniti d'America 7.619
IE - Irlanda 3.112
UA - Ucraina 954
IT - Italia 910
GB - Regno Unito 815
DE - Germania 689
SG - Singapore 457
CN - Cina 439
FI - Finlandia 267
GR - Grecia 248
SE - Svezia 213
TR - Turchia 182
FR - Francia 115
BE - Belgio 43
NL - Olanda 33
CZ - Repubblica Ceca 27
PL - Polonia 15
RS - Serbia 13
IN - India 12
CA - Canada 10
EU - Europa 9
IR - Iran 9
HK - Hong Kong 8
MX - Messico 8
BR - Brasile 7
RU - Federazione Russa 7
MK - Macedonia 6
ET - Etiopia 5
BO - Bolivia 4
DK - Danimarca 4
ES - Italia 4
PK - Pakistan 4
AT - Austria 3
EG - Egitto 3
ID - Indonesia 3
JP - Giappone 3
RO - Romania 3
TW - Taiwan 3
AR - Argentina 2
BD - Bangladesh 2
CD - Congo 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
NZ - Nuova Zelanda 2
PE - Perù 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
GT - Guatemala 1
MA - Marocco 1
MT - Malta 1
MY - Malesia 1
PA - Panama 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
Totale 16.298
Città #
Dublin 3.110
Jacksonville 1.474
Chandler 1.014
Wilmington 546
Chicago 535
Princeton 410
Falls Church 345
Roxbury 318
Bremen 314
Singapore 256
Ann Arbor 221
Medford 212
Cambridge 211
Caserta 196
New York 193
Boardman 156
Woodbridge 111
Beijing 110
San Mateo 99
Ashburn 98
Des Moines 90
Houston 89
Naples 88
Mountain View 50
Jinan 46
Nanjing 44
Napoli 43
Brussels 41
Düsseldorf 37
Washington 36
Auburn Hills 28
Helsinki 28
Milan 28
Brno 25
Marano 24
Munich 22
Shenyang 22
Amsterdam 21
Los Angeles 21
Nanchang 21
Rome 21
Norwalk 20
Kunming 17
Lappeenranta 16
Hangzhou 14
Kraków 14
Redwood City 14
Zhengzhou 14
Hebei 13
Aversa 12
Dearborn 12
Venice 12
Grafing 11
Ariano Irpino 10
Guangzhou 10
Lanzhou 10
London 10
Groningen 9
Ningbo 9
Paris 9
Altamura 8
Bari 8
Hefei 8
Salerno 8
Tianjin 8
Catania 7
Jiaxing 7
Marano Di Napoli 7
Seattle 7
Zanjan 7
Changsha 6
Haikou 6
Boydton 5
Fairfield 5
Guadalajara 5
Hong Kong 5
Leawood 5
Nocera Inferiore 5
Putignano 5
San Lazzaro di Savena 5
Sant'anastasia 5
Sennori 5
Taizhou 5
Bagheria 4
Belgrade 4
Cercola 4
Cesa 4
Como 4
Hanover 4
La Paz 4
Limbiate 4
Marco 4
Portici 4
Pune 4
San Nicola la Strada 4
Shanghai 4
Taiyuan 4
Torre Del Greco 4
Afragola 3
Arzano 3
Totale 11.198
Nome #
The role of bacterial colonization of the suture thread in early identification and targeted antibiotic treatment of surgical site infections: A prospective cohort study 1.310
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 107
Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven hepatitis C: a multicenter study 105
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 90
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 86
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 84
Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: A retrospective study 82
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 81
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 78
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 76
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 76
Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme? 75
An attempt to improve classification of HCV-correlated chronic hepatitis 74
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 74
PREVALENCE OF LATENT TUBERCULOSIS INFECTION IN HEALTHCARE WORKERS AT A HOSPITAL IN NAPLES, ITALY, A LOW-INCIDENCE COUNTRY 73
null 71
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 71
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 70
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 69
Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy 68
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 67
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 66
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 66
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 65
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 64
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 63
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 62
The TM6SF2 E167K variant in HIV/HCV coinfection predicts severe liver fibrosis and, only for patients with HCV genotype non 3 severe steatosis. 61
964 HBV occult infection in patients with chronic hepatitis C: a multicentric prospective study 60
Erratum: Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme (Journal of Occupational Medicine and Toxicology (2015) 10:41) 60
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 59
Impact of comorbidities on the severity of chronic hepatitis B at presentation 59
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 59
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 58
Does HIV infection favor the sexual transmission of hepatitis C? 58
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 58
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 58
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 58
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 57
Suture thread check test for detection of surgical site contamination: a prospective study 57
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 56
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 56
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients. 56
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 55
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 55
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 55
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 55
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 55
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. 55
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 55
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases 54
Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation 54
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 54
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 54
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 53
Acute liver failure: a rare clinical presentation of visceral leishmaniasi 53
Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. 53
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 53
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 53
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 52
Anti-HBc positività was associated with histological cirrhosis in patients with chronic hepatitis C 52
4. Infezioni da Salmonelle non-tifoidee: nuovi aspetti epidemiologici 52
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 52
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 52
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 51
Helicobacter spp. and liver diseases. 51
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 50
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 50
Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases 50
Absence of occult HCV infection in HIV-positive patients 50
Treatment of chronic HBV infection in developing countries. 50
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 50
Is the liver biopsy necessary for hepatitis C virus carriers with persistently normal aminotransferase levels? 49
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 49
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 49
Can HCV affect the efficacy of anti-HIV treatment? 49
[639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME 49
Clinical significance of hepatitis B surface antigen mutants 49
Risk factors for carotid atherosclerosis in chronic hepatitis C: no role of the APOC3 variant 49
Distribution pattern of hepatitis C Virus genotypes and correlation with viral load and risk factors in chronic positive patients 48
Clinical and virological characteristics associated with severe acute hepatitis B 48
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 48
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 48
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 48
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 48
Olfactory loss and brain connectivity after COVID-19 48
Liver Histology in Patients With HBsAg Negative Anti-HBc and Anti-HCV Positive Chronic Hepatitis 47
Virological patterns of HCV patients with failure to interferon-free regimens. 47
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 47
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 47
Role of genetic polymorphisms in hepatitis C virus chronic infection 46
EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS 46
HAV replication in acute hepatitis with typical and atypical clinical course 45
Asunaprevir, a protease inhibitor for the treatment of HCV infection 45
Anti-HCV IgG avidity index in acute hepatitis C. 45
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: Contribution of universal HBV vaccination in Italy 45
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 45
HBV vaccination status among healthcare workers: A cross-sectional study 45
Reply : Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer 44
Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART 44
Totale 7.048
Categoria #
all - tutte 77.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.698 338 289 35 28 260 72 338 99 121 50 58 10
2020/20212.198 173 18 234 87 377 59 333 270 48 266 291 42
2021/20223.223 179 157 255 126 808 61 155 63 100 242 228 849
2022/20235.606 548 179 373 305 632 325 10 249 2.760 34 101 90
2023/20242.349 180 82 132 177 822 244 31 63 27 33 156 402
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 17.093